undefined undefined
NaN.000
NaN.00%
Needham analyst Joseph Stringer reiterates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Hold.
05-07 19:27
Piper Sandler analyst Christopher Raymond maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight and raises the price target from $450 to $456.
05-07 19:16
Vertex Pharmaceuticals (NASDAQ:VRTX) has continued its string of quarterly EPS beats as net income in Q1 2024, on a non-GAAP basis, surged ~56% compared to the year-ago period. Non-GAAP net income in ...
05-07 05:21
Vertex's product revenue guidance includes expectations for continued growth in CF as well as for the launch of CASGEVY in approved indications and geographies.
05-07 04:26
bluebird bio (NASDAQ:BLUE) said it has completed the first commercial cell collection for its one-time gene therapy Lyfgenia for the treatment of sickle cell disease. The patient’s cells were collecte...
05-07 00:44
Investors with a lot of money to spend have taken a bullish stance on Vertex Ph...
05-07 00:15
当地时间2024年5月3日,美股三大指数集体收涨,纳指涨1.99%,标普500指数涨1.26%,道指涨1.18%。纳指生物科技指数收涨1.66%,ARDELY...
05-06 13:49
Major earnings expected after the bell on Monday include: Palantir Technologies (PLTR) Realty Income Corporation (O) Lucid Group (LCID) Simon Property Group (SPG) Vertex Pharmaceuticals Incorporated (...
05-06 05:35
As Wall Street embarks on the first full week of May, a diverse group of companies is set to report financial results. Notable names include The Walt Disney Company (NYSE:DIS), Palantir Technologies...
05-05 20:00
美股下周应该关注什么? 文 | 美股研究社 美股周五收高,三大股指本周均录得涨幅。美国4月非农就业数据远逊预期,失业率上升、薪酬增长放缓,使市场对美联储今年降息...
05-04 21:23